Glycomic analysis of ovarian cancer: Past, present, and future

被引：7
|
作者：
Abbott, Karen L. [1 ]
机构：
[1] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA
来源：
CANCER BIOMARKERS | 2010年 / 8卷 / 4-5期
关键词：
SERUM; GLYCOSYLATION; BIOMARKERS; IDENTIFICATION; PROTECTION; ANTIBODIES; ENRICHMENT; CONJUGATE; DISCOVERY; VACCINES;
D O I：
10.3233/CBM-2011-0218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Glycosylation is undeniably the most complex posttranslational modification. Glycan structures found on proteins and lipids are diverse, often changing in different tissues from normal physiologic conditions to diseases such as cancer. Glycomics encompasses the study of glycans along with the proteins and lipids to which they are attached. In this review we will discuss the glycomics of ovarian cancer from the pre- mass spectrometry era to current discoveries and finally to future potential clinical applications of research based on glycomic discoveries.
引用
收藏
页码：273 / 280
页数：8
相关论文
共 50 条
  • [1] Anthracyclines in ovarian cancer - Past, present and future
    du Bois, A
    ONKOLOGIE, 2000, 23 : 46 - 52
  • [2] The genomic of epithelial ovarian cancer: the past, present, and future
    Birrer, Michael J.
    Wei, Wei
    Ceppi, Lorenzo
    Tsang, Tsun Yee
    ANNALS OF ONCOLOGY, 2015, 26 : 27 - 27
  • [3] Past, present and future targets for immunotherapy in ovarian cancer
    Schwab, Carlton L.
    English, Diana P.
    Roque, Dana M.
    Pasternak, Monica
    Santin, Alessandro D.
    IMMUNOTHERAPY, 2014, 6 (12) : 1279 - 1293
  • [4] Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future
    Fields, Emma C.
    McGuire, William P.
    Lin, Lilie
    Temkin, Sarah M.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [5] VSV based virotherapy in ovarian cancer: the past, the present and ...future?
    Orzechowska, Beata Urszula
    Jedryka, Marcin
    Zwolinska, Katarzyna
    Matkowski, Rafal
    JOURNAL OF CANCER, 2017, 8 (12): : 2369 - 2383
  • [6] Ovarian hyperstimulation: past, present, and future
    Feinberg, Eve C.
    FERTILITY AND STERILITY, 2016, 106 (06) : 1330 - 1330
  • [7] Primary debulking surgery for advanced ovarian cancer: Is it the past, present, or future?
    Schorge, J.
    McCann, C.
    Growdon, W.
    Boruta, D.
    Del Carmen, M.
    Goodman, A.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S130 - S130
  • [8] Clinical trials in patients with epithelial ovarian cancer: Past, present and future
    Vermorken, JB
    Pecorelli, S
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (05): : 455 - 466
  • [9] Anti-angiogenic agents in ovarian cancer: past, present, and future
    Monk, B. J.
    Minion, L. E.
    Coleman, R. L.
    ANNALS OF ONCOLOGY, 2016, 27 : 33 - 39
  • [10] Ovarian and cervical cancer patient derived xenografts: The past, present, and future
    Boone, Jonathan D.
    Dobbin, Zachary C.
    Straughn, J. Michael, Jr.
    Buchsbaum, Donald J.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 486 - 491
12345